These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9378535)

  • 1. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
    Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
    Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
    Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
    J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
    Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.
    Sankar S; Mahooti-Brooks N; Bensen L; McCarthy TL; Centrella M; Madri JA
    J Clin Invest; 1996 Mar; 97(6):1436-46. PubMed ID: 8617876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
    Woodward JK; Rennie IG; Burn JL; Sisley K
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM; Collins KL; Diamond MP
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
    Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta.
    Shiou SR; Datta PK; Dhawan P; Law BK; Yingling JM; Dixon DA; Beauchamp RD
    J Biol Chem; 2006 Nov; 281(45):33971-81. PubMed ID: 16959768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
    Sandberg T; Casslén B; Gustavsson B; Benraad TJ
    Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular types I and II transforming growth factor-beta receptor expression: differential dependency on tyrosine kinases during induction by TGF-beta.
    Ward MR; Agrotis A; Jennings G; Bobik A
    FEBS Lett; 1998 Jan; 422(2):197-200. PubMed ID: 9490005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
    DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.